About DNA dC->dU-editing enzyme APOBEC-3G
DNA dC->dU-editing enzyme APOBEC-3G (APOBEC3G) is a protein
from Homo sapiens identified by UniProt accession
Q9HC16, 384 residues long.
MolForge cross-references it against 0 known binders and
166 disease associations.
Target properties
| Protein name | DNA dC->dU-editing enzyme APOBEC-3G |
| UniProt accession | Q9HC16 |
| Gene | APOBEC3G |
| Organism | Homo sapiens |
| Length | 384 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (166)
Diseases linked to this target (Open Targets).
- HIV infection · score 0.56
- lymphocyte count · score 0.29
- inflammatory bowel disease · score 0.13
- glioblastoma multiforme · score 0.08
- monocyte count · score 0.08
- immune deficiency, familial variable · score 0.08
- immunodeficiency 35 · score 0.07
- leukocyte count · score 0.07
- Chronic mucocutaneous candidosis · score 0.07
- hyper-IgM syndrome type 2 · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9HC16-F1 | alphafold | PREDICTED | 88.56 | — |
Amino-acid sequence (384 residues)
MKPHFRNTVE RMYRDTFSYN FYNRPILSRR NTVWLCYEVK TKGPSRPPLD AKIFRGQVYS ELKYHPEMRF FHWFSKWRKL HRDQEYEVTW YISWSPCTKC TRDMATFLAE DPKVTLTIFV ARLYYFWDPD YQEALRSLCQ KRDGPRATMK IMNYDEFQHC WSKFVYSQRE LFEPWNNLPK YYILLHIMLG EILRHSMDPP TFTFNFNNEP WVRGRHETYL CYEVERMHND TWVLLNQRRG FLCNQAPHKH GFLEGRHAEL CFLDVIPFWK LDLDQDYRVT CFTSWSPCFS CAQEMAKFIS KNKHVSLCIF TARIYDDQGR CQEGLRTLAE AGAKISIMTY SEFKHCWDTF VDHQGCPFQP WDGLDEHSQD LSGRLRAILQ NQEN
Explore DNA dC->dU-editing enzyme APOBEC-3G with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets